Marriott Marquis

OPKO Health to Participate in the Jefferies Global Healthcare Conference

Retrieved on: 
금요일, 5월 31, 2024
Conference, OPKO Health, Marriott Marquis, Health

MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City.

Key Points: 
  • MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City.
  • Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Thursday, June 6th at 10:30 a.m. Eastern time.

Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Retrieved on: 
목요일, 5월 30, 2024
Marriott Marquis, Jefferies, Conference, CNS, Webcast, Central nervous system

ROCKVILLE, Md., May 30, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 1:30 p.m.

Key Points: 
  • ROCKVILLE, Md., May 30, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 1:30 p.m.
  • ET at the Marriott Marquis Hotel in New York City.
  • Investors interested in arranging a meeting with company management during the conference should contact the Jefferies conference coordinator.
  • An archived replay of the webcast will be available for 60 days on the Company's website following the conference.

Enterome to Participate in the Jefferies Global Healthcare Conference

Retrieved on: 
목요일, 5월 30, 2024
Conference, Inflammation, Marriott Marquis

PARIS, May 30, 2024 (GLOBE NEWSWIRE) -- Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry platform, today announces that Pierre Bélichard, Enterome’s co-founder and Chief Executive Officer, and Christelle Dumoussaud, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on June 4-6, 2024.

Key Points: 
  • PARIS, May 30, 2024 (GLOBE NEWSWIRE) -- Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry platform, today announces that Pierre Bélichard, Enterome’s co-founder and Chief Executive Officer, and Christelle Dumoussaud, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on June 4-6, 2024.

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference

Retrieved on: 
목요일, 5월 30, 2024
Patient, Marriott Marquis, Therapy, Conference, TCR, Cancer, Webcast

WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced that the Company will present at the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on Wednesday, June 5, 2024 at 11:00 a.m. Eastern Time.

Key Points: 
  • WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced that the Company will present at the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on Wednesday, June 5, 2024 at 11:00 a.m. Eastern Time.
  • A webcast of the presentation will be available on the “ Events and Presentations ” section of the Company’s website at ir.tscan.com .
  • An archived replay of the webcast will be available on the Company’s website for 90 days following the event.

Indaptus Therapeutics to Present at the Jefferies Global Healthcare Conference

Retrieved on: 
목요일, 5월 30, 2024
Conference, Therapy, Viral, Marriott Marquis

NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, announces today that Jeffrey Meckler, Chief Executive Officer, and Roger Waltzman, M.D., M.B.A., Chief Medical Officer, will present a corporate overview at the Jefferies Global Healthcare Conference.

Key Points: 
  • NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, announces today that Jeffrey Meckler, Chief Executive Officer, and Roger Waltzman, M.D., M.B.A., Chief Medical Officer, will present a corporate overview at the Jefferies Global Healthcare Conference.
  • The conference is being held on June 5 – 6, 2024 at the Marriott Marquis in New York City.

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Retrieved on: 
목요일, 5월 30, 2024
Biotechnology, Other Health, Health, General Health, Public Relations, Investor Relations, Pharmaceutical, Communications, Neurology, Health Technology, Medical Devices, Fitness & Nutrition, Conference, Software, Medication, Webcast, Marriott Marquis, Ironwood Pharmaceuticals

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m.

Key Points: 
  • Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m.
  • A live webcast of Ironwood’s fireside chat will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com .
  • To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required.
  • A replay of the webcast will be available on Ironwood’s website for 1 year following the conference.

Cardiff Oncology to Present at the Jefferies Healthcare Conference

Retrieved on: 
수요일, 5월 29, 2024
CRDF, PLK1, Cancer, Interest, SAN, Marriott Marquis, Conference

SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in a company presentation and 1x1 investor meetings at the Jefferies Healthcare Conference, which is taking place at the Marriott Marquis in New York from June 5-6, 2024.

Key Points: 
  • SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in a company presentation and 1x1 investor meetings at the Jefferies Healthcare Conference, which is taking place at the Marriott Marquis in New York from June 5-6, 2024.
  • Details of the presentations can be found below.
  • Interested parties can register for and access the live webcasts for these conferences by visiting the “ Events ” section of the Cardiff Oncology website.
  • The webcast replays will be available after the conclusion of the respective presentations.

Immuneering to Present at the Jefferies Global Healthcare Conference

Retrieved on: 
수요일, 5월 29, 2024
Conference, Patient, Cancer, CPA, Marriott Marquis

CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced that management will participate in the Jefferies Global Healthcare Conference, which is taking place at the Marriott Marquis in New York City from June 5-6, 2024, to discuss the company’s pipeline, platform, and business strategy.

Key Points: 
  • CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced that management will participate in the Jefferies Global Healthcare Conference, which is taking place at the Marriott Marquis in New York City from June 5-6, 2024, to discuss the company’s pipeline, platform, and business strategy.
  • Participating will be Ben Zeskind, Co-founder and Chief Executive Officer, and Mallory Morales, CPA, Chief Accounting Officer, Treasurer.

Equillium to Present at the Jefferies Global Healthcare Conference

Retrieved on: 
수요일, 5월 29, 2024
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Partnership, Therapy, Ono Pharmaceutical, Marriott Marquis, Conference

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the Jefferies Global Healthcare Conference taking place at the Marriott Marquis in New York, NY, June 4 – 6, 2024.

Key Points: 
  • Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the Jefferies Global Healthcare Conference taking place at the Marriott Marquis in New York, NY, June 4 – 6, 2024.
  • Management will provide an overview of the company’s clinical programs – including EQ101 for the treatment for alopecia areata with data expected before the end of June 2024 – the company’s partnership with Ono Pharmaceutical, and 2024 milestones.
  • Management will also be available for one-on-one meetings during the conference.

Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference

Retrieved on: 
화요일, 5월 28, 2024
Conference, Therapy, Marriott Marquis, SAN, DSM-IV codes

SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for the potential treatment of neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona’s Co-Founder and Chief Executive Officer, is scheduled to host investor meetings at the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on June 4-6, 2024.

Key Points: 
  • SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for the potential treatment of neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona’s Co-Founder and Chief Executive Officer, is scheduled to host investor meetings at the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on June 4-6, 2024.